These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15007143)

  • 1. Anti-GQ1b antibody as a factor predictive of mechanical ventilation in Guillain-Barré syndrome.
    Kaida K; Kusunoki S; Kanzaki M; Kamakura K; Motoyoshi K; Kanazawa I
    Neurology; 2004 Mar; 62(5):821-4. PubMed ID: 15007143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-GQ1b antibody as a factor predictive of mechanical ventilation in Guillain-Barré syndrome.
    Haifeng L
    Neurology; 2004 Nov; 63(10):1985; author reply 1985. PubMed ID: 15557541
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical predictors of mechanical ventilation in Fisher/Guillain-Barré overlap syndrome.
    Funakoshi K; Kuwabara S; Odaka M; Hirata K; Yuki N
    J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):60-4. PubMed ID: 18948360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-ganglioside complex antibodies associated with severe disability in GBS.
    Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
    J Neuroimmunol; 2007 Jan; 182(1-2):212-8. PubMed ID: 17113161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
    Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
    J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
    Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
    J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barre syndromes.
    Kanzaki M; Kaida K; Ueda M; Morita D; Hirakawa M; Motoyoshi K; Kamakura K; Kusunoki S
    J Neurol Neurosurg Psychiatry; 2008 Oct; 79(10):1148-52. PubMed ID: 18339728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-GQ1b IgG antibody syndrome: clinical and immunological range.
    Odaka M; Yuki N; Hirata K
    J Neurol Neurosurg Psychiatry; 2001 Jan; 70(1):50-5. PubMed ID: 11118247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
    Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
    Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum IgG anti-GD1a antibody and mEGOS predict outcome in Guillain-Barré syndrome.
    Yamagishi Y; Kuwahara M; Suzuki H; Sonoo M; Kuwabara S; Yokota T; Nomura K; Chiba A; Kaji R; Kanda T; Kaida KI; Mutoh T; Yamasaki R; Takashima H; Matsui M; Nishiyama K; Sobue G; Kusunoki S
    J Neurol Neurosurg Psychiatry; 2020 Dec; 91(12):1339-1342. PubMed ID: 33041261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GQ1b antibody testing in Guillain-Barre syndrome and variants.
    Chaudhry F; Gee KE; Vaphiades MS; Biller J; Jay W
    Semin Ophthalmol; 2006; 21(4):223-7. PubMed ID: 17182410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-GQ1b IgG-negative case of overlapping Fisher's and Gullain-Barré syndromes after Campylobacter jejuni (PEN 19) enteritis].
    Hayashi Y; Koga M; Takahashi M; Uchida A; Yuki N
    Rinsho Shinkeigaku; 2001 Nov; 41(11):801-4. PubMed ID: 12080613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-GT1a IgG in Guillain-Barré syndrome.
    Koga M; Yoshino H; Morimatsu M; Yuki N
    J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):767-71. PubMed ID: 12023422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of testing kits of anti-ganglioside antibody: clinical utility in Guillain-Barré and Fisher syndromes].
    Akiyama M; Koga M; Yoshino H; Hamaoka A; Noguchi Y; Hirata K; Yuki N
    No To Shinkei; 2006 Jun; 58(6):477-81. PubMed ID: 16856515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ataxic Guillain-Barré syndrome with anti-GQ1b antibody: relation to Miller Fisher syndrome.
    Yuki N; Susuki K; Hirata K
    Neurology; 2000 May; 54(9):1851-3. PubMed ID: 10802797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin G subclass distribution of autoantibodies to gangliosides in patients with Guillain-Barre syndrome.
    Ilyas AA; Chen ZW; Cook SD; Mithen FA; Singhal BS
    Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):115-23. PubMed ID: 11458979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fulminant Guillain-Barré syndrome showing severe pharyngeal-cervical-brachial weakness in the recovery phase: a case report.
    Nakamura Y; Motoki M; Hirose T; Hosokawa T; Ishida S; Arawaka S
    BMC Neurol; 2019 Jun; 19(1):145. PubMed ID: 31253118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain-Barré syndrome associated with IgG monospecific to ganglioside GD1b.
    Miyazaki T; Kusunoki S; Kaida K; Shiina M; Kanazawa I
    Neurology; 2001 May; 56(9):1227-9. PubMed ID: 11342695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination.
    Nishimoto Y; Odaka M; Hirata K; Yuki N
    J Neuroimmunol; 2004 Mar; 148(1-2):200-5. PubMed ID: 14975602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.